| Literature DB >> 33938025 |
Zhimin Hu1, Xiuyu Liu1,2, Mei Tian1, Ying Ma1, Baolong Jin1, Wei Gao3, Guanghong Cui1, Juan Guo1, Luqi Huang1.
Abstract
Diterpenoids, including more than 18,000 compounds, represent an important class of metabolites that encompass both phytohormones and some industrially relevant compounds. These molecules with complex, diverse structures and physiological activities, have high value in the pharmaceutical industry. Most medicinal diterpenoids are extracted from plants. Major advances in understanding the biosynthetic pathways of these active compounds are providing unprecedented opportunities for the industrial production of diterpenoids by metabolic engineering and synthetic biology. Here, we summarize recent developments in the field of diterpenoid biosynthesis from medicinal herbs. An overview of the pathways and known biosynthetic enzymes is presented. In particular, we look at the main findings from the past decade and review recent progress in the biosynthesis of different groups of ringed compounds. We also discuss diterpenoid production using synthetic biology and metabolic engineering strategies, and draw on new technologies and discoveries to bring together many components into a useful framework for diterpenoid production.Entities:
Keywords: biosynthetic pathway; cytochrome P450; diterpene synthase; heterologous production; plant diterpenoids; synthetic biology
Mesh:
Substances:
Year: 2021 PMID: 33938025 DOI: 10.1002/med.21816
Source DB: PubMed Journal: Med Res Rev ISSN: 0198-6325 Impact factor: 12.944